Navigation Links
Ben-Gurion University of the Negev professor awarded the 2010 Elkeles Prize for Cancer Research
Date:8/8/2010

BEER-SHEVA, ISRAEL, August 9, 2010 Ben-Gurion University of the Negev (BGU) Professor Ron N. Apte has been awarded the 2010 Samuel and Paula Elkeles Prize for Outstanding Scientist in the Field of Medicine.

Professor Apte is chairman of the Shraga Segal Department of Microbiology and Immunology and vice dean of the Basic Sciences division in the BGU Faculty of Health Sciences. He is also the Irving Sklar Chair in Endocrinology and Cancer and a member of the National Institute for Biotechnology in the Negev.

Apte's major field of research involves inflammation in malignant processes. Approximately 15 percent of cancers are connected to inflammation, which typically result in organs where chronic inflammation has occurred. For example, patients with Inflammatory Bowel Disease (IBD) are more prone to cancer than the general population.

The pioneering studies of Apte's group demonstrated the feasibility of intervening in malignant process by neutralizing inflammatory components in the "normal" microenvironment of a tumor. They also detailed the basic concepts underlying such treatment.

Inflammatory cells affect proliferation and invasiveness of malignant cells through the secretion of cytokines, which include Interleukin-1 (IL-1), the molecule that has been studied for years by Apte's group. The group has demonstrated the involvement of IL-1-mediated inflammation in tumor invasiveness and metastasis. IL-1 causes tumor expansion because it suppresses the immune system and nourishes a tumor's blood vessels. Apte's group treated tumor-bearing mice with a specific inhibitor of IL-1, known as the IL-1 receptor antagonist (IL-Ra), and succeeded in weakening the tumor's invasiveness.

IL-Ra, in its generic form Anakirna, is a medication that efficiently alleviates symptoms of patients suffering from rheumatoid arthritis, a chronic inflammatory disease.

Apte joined the BGU Faculty of Sciences in 1981 and has served two full terms as vice dean, as the vice dean of Student Affairs, and as the vice dean for Graduate Studies. Since 2008, he has been the vice dean for Basic Science Affairs.

Apte has been a member of the board of the European Cytokine Society since 1989 and has served on the board of its journal, "The European Cytokine Network". He was also president of the Israel Immunological Society from 1996 to 1998.

Apte has served as a charter member of the International Cancer Microenvironment Society (ICMS) and as an editorial board member of its journal "Cancer Microenvironment". Prof. Apte has published more than 80 papers in the fields of immunology, tumor biology and cytokine biology.


'/>"/>

Contact: Andrew Lavin
andrewlavin@alavin.com
516-353-2505
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Related biology news :

1. Ben-Gurion University of the Negev researchers identify risks of hypertension in young adults
2. FDA approves trial for type 1 diabetes treatment by Ben-Gurion U. and U. Colorado
3. Ben-Gurion U researchers isolate microalgal strain that could reduce cholesterol
4. Uniform method to interpret autism spectrum disorders is defined at Ben-Gurion University
5. Anti-inflammatory drugs (coxibs) interfere with aspirins clotting ability -- Ben-Gurion U.
6. Heartburn drugs deemed safe for fetuses according to Ben-Gurion University researchers
7. Ben-Gurion University Alzheimers researcher demonstrates specific immune response to vaccine
8. Ben-Gurion University of the Negev technology being developed for use in Jordan desalination plant
9. Ben-Gurion U. developing new computer techniques to analyze historic Hebrew and Arabic documents
10. 1 in 6 health workers wont report in flu pandemic -- study by Ben-Gurion U. researchers
11. Ben-Gurion U. researchers reveal connection between cancer and human evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/1/2016)... , June 1, 2016 Favorable ... Election Administration and Criminal Identification to Boost Global Biometrics ... recently released TechSci Research report, " Global Biometrics Market ... Competition Forecast and Opportunities, 2011 - 2021", the global ... by 2021, on account of growing security concerns across ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... a new line of intelligent tools designed, tuned and optimized exclusively for Okuma ... 12–17 in Chicago. The result of a collaboration among several companies with expertise ...
(Date:6/22/2016)... 2016 Research and Markets has announced the ... to their offering. The ... $29.3 billion in 2013. The market is expected to grow at ... to 2020, increasing from $50.6 billion in 2015 to $96.6 billion ... the forecast period (2015 to 2020) are discussed. As well, new ...
(Date:6/22/2016)... 2016   ViaCyte, Inc. , a privately-held regenerative ... replacement therapy for the treatment of diabetes in clinical-stage ... Meeting.  ISSCR 2016, the Global Stem Cell Event, is ... in San Francisco.    ... follows:Event: , Focus Session: Tools for Basic and Applied ...
(Date:6/22/2016)... TAMPA, Fla. and ALBANY, ... Life Sciences Corporation (Teewinot) and Albany Molecular Research, ... that AMRI has licensed Teewinot,s technology to produce ... (CBCA) analytical standard. The CBCA analytical standard is ... processes involve the expression of cannabinoid biosynthetic genes ...
Breaking Biology Technology: